Application Progress of the Single Domain Antibody in Medicine
Open Access
- 20 February 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (4) , 4176
Abstract
The camelid-derived single chain antibody (sdAb), also termed VHH or nanobody, is a unique, functional heavy (H)-chain antibody (HCAb). In contrast to conventional antibodies, sdAb is a unique antibody fragment consisting of a heavy-chain variable domain. It lacks light chains and a first constant domain (CH1). With a small molecular weight of only 12~15 kDa, sdAb has a similar antigen-binding affinity to conventional Abs but a higher solubility, which exerts unique advantages for the recognition and binding of functional, versatile, target-specific antigen fragments. In recent decades, with their unique structural and functional features, nanobodies have been considered promising agents and alternatives to traditional monoclonal antibodies. As a new generation of nano-biological tools, natural and synthetic nanobodies have been used in many fields of biomedicine, including biomolecular materials, biological research, medical diagnosis and immune therapies. This article briefly overviews the biomolecular structure, biochemical properties, immune acquisition and phage library construction of nanobodies and comprehensively reviews their applications in medical research. It is expected that this review will provide a reference for the further exploration and unveiling of nanobody properties and function, as well as a bright future for the development of drugs and therapeutic methods based on nanobodies.Keywords
Funding Information
- National Natural Science Foundation of China (32060783, 2022B-100, GAU-QDFC-2022-11)
- Innovation Fund of Gansu Agricultural University (32060783, 2022B-100, GAU-QDFC-2022-11)
- Science and Technology Innovation Fund of Gansu Agricultural University (32060783, 2022B-100, GAU-QDFC-2022-11)
This publication has 130 references indexed in Scilit:
- Preparation of a Naïve Library of Camelid Single Domain Antibodies2012
- Dual Beneficial Effect of Interloop Disulfide Bond for Single Domain Antibody FragmentsJournal of Biological Chemistry, 2012
- CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cellsProceedings of the National Academy of Sciences, 2010
- β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7Proceedings of the National Academy of Sciences, 2009
- CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculatureProceedings of the National Academy of Sciences, 2007
- Supercharging Proteins Can Impart Unusual ResilienceJournal of the American Chemical Society, 2007
- Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)Journal of Immunological Methods, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Efficient tumor targeting by single‐domain antibody fragments of camelsInternational Journal of Cancer, 2002
- Camel heavy‐chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen‐binding repertoireThe EMBO Journal, 2000